Is This Blue Chip Dividend Stock a Buy for Growth Investors?

The right companies can help investors improve their personal balance sheets. That is because businesses that reliably grow sales and earnings become more valuable to financial markets with each passing year.An investor who put $3,000 into AstraZeneca (NASDAQ: AZN) five years ago https://www.nasdaq.com/articles/is-this-blue-chip-dividend-stock-a-buy-for-growth-investors